MedPath

Gentian Violet

Generic Name
Gentian Violet
Drug Type
Small Molecule
Chemical Formula
C25H30N3
CAS Number
7438-46-2
Unique Ingredient Identifier
3GVJ31T6YY

Overview

A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.

Indication

For the treatment of bacterial and fungal infections inside the mouth (thrush) and skin, also for the prevention of transmission of Chagas' disease (as a blood additive).

Associated Conditions

  • Bacterial Infection of the umbilical cord area
  • Fungal Infection of the umbilical cord area
  • Fungal Infections
  • Infection

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2020/05/14
Phase 2
Not yet recruiting
2011/09/02
Phase 3
Completed
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
TRIPLE DYE
frank w. kerr chemical company
00592919
Liquid - Topical
2.29 MG / ML
12/31/1983
GENTIANE VIOLET LIQ TOP
laboratoire atlas inc
00050857
Liquid - Topical
1 %
12/31/1951

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.